Solopova, Elena http://orcid.org/0000-0001-5508-0368
Romero-Fernandez, Wilber http://orcid.org/0000-0001-9868-8074
Harmsen, Hannah
Ventura-Antunes, Lissa
Wang, Emmeline
Shostak, Alena
Maldonado, Jose http://orcid.org/0000-0002-8008-7059
Donahue, Manus J.
Schultz, Daniel http://orcid.org/0009-0002-1412-1463
Coyne, Thomas M.
Charidimou, Andreas
Schrag, Matthew http://orcid.org/0000-0001-7048-0503
Funding for this research was provided by:
This case study was made possible by philanthropic support from the family and friends of Louis Stephen Zuzga Moran and the family and friends of Douglas B. Janney, Jr.
Article History
Received: 26 April 2023
Accepted: 24 November 2023
First Online: 12 December 2023
Competing interests
: M.J.D. receives research-related support from Philips North America; is a paid consultant for Pfizer Inc, Alterity, Global Blood Therapeutics, Graphite Bio, and LymphaTouch; is a paid advisory board member for Novartis and Bluebird Bio; receives research funding from Pfizer Inc; and is the President/CEO of Biosight, LLC, which operates as a clinical research organization. A.C. reports receiving funding from the Bodossaki Foundation and the Frechette Family Foundation and consulting fees from Imperative Care. M.S. reports receiving funding from the American Federation of Aging Research, the National Institutes of Health, and consulting fees from Labaton-Sucharow LLP and Raymond James. The other authors declare no competing interests.